Driehaus Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
TSMC
TSM
|
+$54.2M |
| 2 |
Nice
NICE
|
+$34.6M |
| 3 |
Yum China
YUMC
|
+$32.6M |
| 4 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$28.8M |
| 5 |
VEON
VEON
|
+$26.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Petrobras
PBR
|
+$45M |
| 2 |
ARRY
Array Biopharma Inc
ARRY
|
+$38.7M |
| 3 |
NBIS
Nebius Group N.V.
NBIS
|
+$25.1M |
| 4 |
HUYA
Huya Inc
HUYA
|
+$22.9M |
| 5 |
Abbott
ABT
|
+$19.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.38% |
| 2 | Healthcare | 21.25% |
| 3 | Consumer Discretionary | 16.71% |
| 4 | Financials | 14.14% |
| 5 | Industrials | 8.3% |
Similar funds
Driehaus Capital Management's Q2 2019 Portfolio in Review
As of Q2 2019, Driehaus Capital Management held 583 positions worth $3.19B, up 20% from $2.66B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Driehaus Capital Management deployed $284M of net new capital in Q2 2019, opening 195 new positions and adding to 123 existing holdings. Its largest new stake was Yum China: 750,359 shares worth $34.7M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Array Biopharma Inc, an estimated $38.7M trimmed.
- Driehaus Capital Management's largest Q2 2019 buy was Yum China: 750,359 shares worth $34.7M.
- Driehaus Capital Management added most to TSMC in Q2 2019, an estimated $54.2M increase.
- Driehaus Capital Management's biggest Q2 2019 reduction was Array Biopharma Inc, cutting an estimated $38.7M.
- Driehaus Capital Management fully exited Petrobras in Q2 2019, selling an estimated $45M.
- Driehaus Capital Management's ten largest holdings make up 25% of its $3.19B portfolio in Q2 2019.
- Driehaus Capital Management opened 195 new positions and closed 125 in Q2 2019.
- Driehaus Capital Management's portfolio value rose 20% quarter-over-quarter to $3.19B.
Based on Driehaus Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.